Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 124

1.

Blunted prefrontal cortical 18fluorodeoxyglucose positron emission tomography response to meta-chlorophenylpiperazine in impulsive aggression.

New AS, Hazlett EA, Buchsbaum MS, Goodman M, Reynolds D, Mitropoulou V, Sprung L, Shaw RB Jr, Koenigsberg H, Platholi J, Silverman J, Siever LJ.

Arch Gen Psychiatry. 2002 Jul;59(7):621-9.

PMID:
12090815
2.

Fluoxetine increases relative metabolic rate in prefrontal cortex in impulsive aggression.

New AS, Buchsbaum MS, Hazlett EA, Goodman M, Koenigsberg HW, Lo J, Iskander L, Newmark R, Brand J, O'Flynn K, Siever LJ.

Psychopharmacology (Berl). 2004 Nov;176(3-4):451-8.

PMID:
15160265
3.

Amygdala-prefrontal disconnection in borderline personality disorder.

New AS, Hazlett EA, Buchsbaum MS, Goodman M, Mitelman SA, Newmark R, Trisdorfer R, Haznedar MM, Koenigsberg HW, Flory J, Siever LJ.

Neuropsychopharmacology. 2007 Jul;32(7):1629-40.

4.

Changes in regional brain glucose metabolism measured with positron emission tomography after paroxetine treatment of major depression.

Kennedy SH, Evans KR, Krüger S, Mayberg HS, Meyer JH, McCann S, Arifuzzman AI, Houle S, Vaccarino FJ.

Am J Psychiatry. 2001 Jun;158(6):899-905.

PMID:
11384897
5.

Effects of m-chlorophenylpiperazine on regional brain glucose utilization: a positron emission tomographic comparison of alcoholic and control subjects.

Hommer D, Andreasen P, Rio D, Williams W, Ruttimann U, Momenan R, Zametkin A, Rawlings R, Linnoila M.

J Neurosci. 1997 Apr 15;17(8):2796-806.

6.

A fenfluramine-activated FDG-PET study of borderline personality disorder.

Soloff PH, Meltzer CC, Greer PJ, Constantine D, Kelly TM.

Biol Psychiatry. 2000 Mar 15;47(6):540-7.

PMID:
10715360
7.

Bilateral medial prefrontal and temporal neocortical hypometabolism in children with epilepsy and aggression.

Juhász C, Behen ME, Muzik O, Chugani DC, Chugani HT.

Epilepsia. 2001 Aug;42(8):991-1001.

8.

Brain serotonin transporter distribution in subjects with impulsive aggressivity: a positron emission study with [11C]McN 5652.

Frankle WG, Lombardo I, New AS, Goodman M, Talbot PS, Huang Y, Hwang DR, Slifstein M, Curry S, Abi-Dargham A, Laruelle M, Siever LJ.

Am J Psychiatry. 2005 May;162(5):915-23.

PMID:
15863793
9.

d,l-fenfluramine response in impulsive personality disorder assessed with [18F]fluorodeoxyglucose positron emission tomography.

Siever LJ, Buchsbaum MS, New AS, Spiegel-Cohen J, Wei T, Hazlett EA, Sevin E, Nunn M, Mitropoulou V.

Neuropsychopharmacology. 1999 May;20(5):413-23.

10.

Positron emission tomography of regional brain metabolic responses to a serotonergic challenge and lethality of suicide attempts in major depression.

Oquendo MA, Placidi GP, Malone KM, Campbell C, Keilp J, Brodsky B, Kegeles LS, Cooper TB, Parsey RV, van Heertum RL, Mann JJ.

Arch Gen Psychiatry. 2003 Jan;60(1):14-22.

PMID:
12511168
11.

Gender differences in a fenfluramine-activated FDG PET study of borderline personality disorder.

Soloff PH, Meltzer CC, Becker C, Greer PJ, Constantine D.

Psychiatry Res. 2005 Apr 30;138(3):183-95.

PMID:
15854787
12.

Prediction of antidepressant effects of sleep deprivation by metabolic rates in the ventral anterior cingulate and medial prefrontal cortex.

Wu J, Buchsbaum MS, Gillin JC, Tang C, Cadwell S, Wiegand M, Najafi A, Klein E, Hazen K, Bunney WE Jr, Fallon JH, Keator D.

Am J Psychiatry. 1999 Aug;156(8):1149-58. Erratum in: Am J Psychiatry 1999 Oct;156(10):1666.

PMID:
10450253
13.

Differential brain metabolic predictors of response to paroxetine in obsessive-compulsive disorder versus major depression.

Saxena S, Brody AL, Ho ML, Zohrabi N, Maidment KM, Baxter LR Jr.

Am J Psychiatry. 2003 Mar;160(3):522-32.

PMID:
12611834
14.

Positron emission tomographic imaging of serotonin activation effects on prefrontal cortex in healthy volunteers.

Mann JJ, Malone KM, Diehl DJ, Perel J, Nichols TE, Mintun MA.

J Cereb Blood Flow Metab. 1996 May;16(3):418-26.

PMID:
8621746
15.

Impulsivity and prefrontal hypometabolism in borderline personality disorder.

Soloff PH, Meltzer CC, Becker C, Greer PJ, Kelly TM, Constantine D.

Psychiatry Res. 2003 Jul 30;123(3):153-63.

PMID:
12928103
16.

Association of methylphenidate-induced craving with changes in right striato-orbitofrontal metabolism in cocaine abusers: implications in addiction.

Volkow ND, Wang GJ, Fowler JS, Hitzemann R, Angrist B, Gatley SJ, Logan J, Ding YS, Pappas N.

Am J Psychiatry. 1999 Jan;156(1):19-26.

PMID:
9892293
17.

Laboratory induced aggression: a positron emission tomography study of aggressive individuals with borderline personality disorder.

New AS, Hazlett EA, Newmark RE, Zhang J, Triebwasser J, Meyerson D, Lazarus S, Trisdorfer R, Goldstein KE, Goodman M, Koenigsberg HW, Flory JD, Siever LJ, Buchsbaum MS.

Biol Psychiatry. 2009 Dec 15;66(12):1107-14. doi: 10.1016/j.biopsych.2009.07.015.

18.

Decreased regional brain metabolism after ect.

Nobler MS, Oquendo MA, Kegeles LS, Malone KM, Campbell CC, Sackeim HA, Mann JJ.

Am J Psychiatry. 2001 Feb;158(2):305-8.

PMID:
11156816
19.

Positron emission tomography metabolic correlates of apathy in Alzheimer disease.

Marshall GA, Monserratt L, Harwood D, Mandelkern M, Cummings JL, Sultzer DL.

Arch Neurol. 2007 Jul;64(7):1015-20.

PMID:
17620493
20.

Increased serotonin 2A receptor availability in the orbitofrontal cortex of physically aggressive personality disordered patients.

Rosell DR, Thompson JL, Slifstein M, Xu X, Frankle WG, New AS, Goodman M, Weinstein SR, Laruelle M, Abi-Dargham A, Siever LJ.

Biol Psychiatry. 2010 Jun 15;67(12):1154-62. doi: 10.1016/j.biopsych.2010.03.013.

Items per page

Supplemental Content

Support Center